Zur Hauptnavigation wechseln Zur Suche wechseln Zum Hauptinhalt wechseln

Circadian period of luciferase expression shortens with age in human mature adipocytes from obese patients

Isa Kolbe, María Paz Carrasco-Benso, Jesús López-Mínguez, Juan Lujan, Frank A.J.L. Scheer, Henrik Oster*, Marta Garaulet

*Korrespondierende/r Autor/-in für diese Arbeit

Abstract

Daily rhythms in physiology and behavior change with age. An unresolved question is to what extent such age-related alterations in circadian organization are driven by the central clock in the suprachiasmatic nucleus (SCN), modifying timing signals to contributing peripheral tissue oscillators, and are mediated by underlying changes in the local cellular oscillators themselves. Using a bioluminescence reporter approach, we sought to determine whether circadian clock function in human adipocytes from subcutaneous (SAT) and visceral (VAT) adipose tissues changeswith age. SAT andVAT biopsies were obtained from obese individuals during gastric bypass surgeries [n = 16; body mass index: 44.8 6 11.4 kg/m2; age: 44 6 9 yr (range: 30-58)]. Cells were isolated and transduced with a lentiviral circadian reporter construct [brain and muscle aryl hydrocarbon receptor nuclear translocator-like:luciferase (BMAL:LUC)], and bioluminescence was recorded over a period of 3 d. Human BMAL1:LUC adipocytes displayed a robust luminescence rhythm with comparable within-individual periods in mature and preadipocytes (P > 0.05).With increasing age, the circadian period decreased in mature adipocytes (P = 0.005) (b = 4 min/yr; P < 0.05). Our ex vivo approach indicated that ageing changes the organization of endogenous circadian oscillators in human adipocytes, independent of SCNsignaling.

OriginalspracheEnglisch
ZeitschriftFASEB Journal
Jahrgang33
Ausgabenummer1
Seiten (von - bis)175-180
Seitenumfang6
ISSN0892-6638
DOIs
PublikationsstatusVeröffentlicht - 01.01.2019

Fördermittel

This work as supported in part by The Spanish Department of Investigation, Development, and Innovation (SAF2017-84135-R) including cofunding from the Spanish Federation of Rare Diseases (FEDER), and U.S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant R01DK105072 (to M.G.); German Research Foundation grants GRK-1957 and SFB-134 (to H.O.); and NIH NIDDK Grant R01 DK099512 and NIH National Heart, Lung and Blood Institute grants R01 HL118601 and R01 HL140574 (to F.A.J.L.S). H.O. is a Lichtenberg fellow of the Volkswagen Foundation. F.A.J.L.S. has received speaker fees from Bayer Healthcare (Montville, NJ, USA), Sentara Healthcare (Norfolk, VA, USA), Kellogg Company (Battle Creek, MI, USA), and Philips (Eindhoven, The Netherlands). The other authors declare no conflicts of interest.

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

  1. SDG 3 – Gesundheit und Wohlergehen
    SDG 3 – Gesundheit und Wohlergehen
  2. SDG 8 – Angemessene Arbeitsbedingungen und wirtschaftliches Wachstum
    SDG 8 – Angemessene Arbeitsbedingungen und wirtschaftliches Wachstum
  3. SDG 10 – Weniger Ungleichheiten
    SDG 10 – Weniger Ungleichheiten

Strategische Forschungsbereiche und Zentren

  • Forschungsschwerpunkt: Gehirn, Hormone, Verhalten - Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Untersuchen Sie die Forschungsthemen von „Circadian period of luciferase expression shortens with age in human mature adipocytes from obese patients“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren